|
1
|
Ebstein AM, Joseph SJ and Hernandez M:
Psychological stress and pancreatic cancer patients: A systematic
review protocol. JBI Evid Synth. 18:576–582. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abdollahi A, Panahipour H, Hosseinian S
and Allen KA: The effects of perceived stress on hope in women with
breast cancer and the role of psychological hardiness.
Psychooncology. 28:1477–1482. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharpley CF, Christie DRH, Bitsika V,
Andronicos NM, Agnew LL, Richards TM and McMillan ME: Comparing a
genetic and a psychological factor as correlates of anxiety,
depression, and chronic stress in men with prostate cancer. Support
Care Cancer. 26:3195–3200. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiriac VF, Baban A and Dumitrascu DL:
Psychological stress and breast cancer incidence: A systematic
review. Clujul Med. 91:18–26. 2018.PubMed/NCBI
|
|
5
|
Zhao L, Xu J, Liang F, Li A, Zhang Y and
Sun J: Effect of chronic psychological stress on liver metastasis
of colon cancer in mice. PLoS One. 10:e01399782015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schuller HM: Effects of tobacco
constituents and psychological stress on the β-adrenergic
regulation of non-small cell lung cancer and pancreatic cancer:
Implications for intervention. Cancer Biomark. 13:133–144. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lutgendorf SK, DeGeest K, Dahmoush L,
Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L,
Krueger G, et al: Social isolation is associated with elevated
tumor norepinephrine in ovarian carcinoma patients. Brain Behav
Immun. 25:250–255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shin KJ, Lee YJ, Yang YR, Park S, Suh PG,
Follo MY, Cocco L and Ryu SH: Molecular mechanisms underlying
psychological stress and cancer. Curr Pharm Des. 22:2389–2402.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elefteriou F: Chronic stress, sympathetic
activation and skeletal metastasis of breast cancer cells. Bonekey
Rep. 4:6932015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moreno-Smith M, Lutgendorf SK and Sood AK:
Impact of stress on cancer metastasis. Future Oncol. 6:1863–1881.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Romana-Souza B, Lima-Cezar GS and
Monte-Alto-Costa A: Psychological stress-induced catecholamines
accelerates cutaneous aging in mice. Mech Ageing Dev. 152:63–73.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu W, Liu S, Liang Y, Zhou Z, Bian W and
Liu X: Stress hormone cortisol enhances Bcl2 like-12 expression to
inhibit p53 in hepatocellular carcinoma cells. Dig Dis Sci.
62:3495–3500. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Webster S, Chandrasekaran S, Vijayaragavan
R and Sethu G: Impact of emotional support on serum cortisol in
breast cancer patients. Indian J Palliat Care. 22:141–149. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Obradovic MMS, Hamelin B, Manevski N,
Couto JP, Sethi A, Coissieux MM, Münst S, Okamoto R, Kohler H,
Schmidt A and Bentires-Alj M: Glucocorticoids promote breast cancer
metastasis. Nature. 567:540–544. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Drebert Z, De Vlieghere E, Bridelance J,
De Wever O, De Bosscher K, Bracke M and Beck IM: Glucocorticoids
indirectly decrease colon cancer cell proliferation and invasion
via effects on cancer-associated fibroblasts. Exp Cell Res.
362:332–342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pufall MA: Glucocorticoids and cancer. Adv
Exp Med Biol. 872:315–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia Y, Wei Y, Li ZY, Cai XY, Zhang LL,
Dong XR, Zhang S, Zhang RG, Meng R, Zhu F and Wu G: Catecholamines
contribute to the neovascularization of lung cancer via
tumor-associated macrophages. Brain Behav Immun. 81:111–121. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang EV: Role for catecholamines in tumor
progression: Possible use for β-blockers in the treatment of
cancer. Cancer Biol Ther. 10:30–32. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Melhem-Bertrandt A, Chavez-Macgregor M,
Lei X, Brown EN, Lee RT, Meric-Bernstam F, Sood AK, Conzen SD,
Hortobagyi GN and Gonzalez-Angulo AM: Beta-blocker use is
associated with improved relapse-free survival in patients with
triple-negative breast cancer. J Clin Oncol. 29:2645–2652. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Flint MS, Baum A, Chambers WH and Jenkins
FJ: Induction of DNA damage, alteration of DNA repair and
transcriptional activation by stress hormones.
Psychoneuroendocrinology. 32:470–479. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jenkins FJ, Van Houten B and Bovbjerg DH:
Effects on DNA damage and/or repair processes as biological
mechanisms linking psychological stress to cancer risk. J Appl
Biobehav Res. 19:3–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Flint MS, Baum A, Episcopo B, Knickelbein
KZ, Dougall AJ, Chambers WH and Jenkins FJ: Chronic exposure to
stress hormones promotes transformation and tumorigenicity of 3T3
mouse fibroblasts. Stress. 16:114–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Satin JR, Linden W and Phillips MJ:
Depression as a predictor of disease progression and mortality in
cancer patients: A meta-analysis. Cancer. 115:5349–5361. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Steel JL, Geller DA, Gamblin TC, Olek MC
and Carr BI: Depression, immunity, and survival in patients with
hepatobiliary carcinoma. J Clin Oncol. 25:2397–2405. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thaker PH, Han LY, Kamat AA, Arevalo JM,
Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori
M, et al: Chronic stress promotes tumor growth and angiogenesis in
a mouse model of ovarian carcinoma. Nat Med. 12:939–944. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Madden KS, Szpunar MJ and Brown EB:
β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by
divergent pathways in high β-AR-expressing breast cancer cell
lines. Breast Cancer Res Treat. 130:747–758. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lutgendorf SK, Lamkin DM, Jennings NB,
Arevalo JM, Penedo F, DeGeest K, Langley RR, Lucci JA III, Cole SW,
Lubaroff DM and Sood AK: Biobehavioral influences on matrix
metalloproteinase expression in ovarian carcinoma. Clin Cancer Res.
14:6839–6846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Zhang Y, He Z, Yin K, Li B, Zhang
L and Xu Z: Chronic stress promotes gastric cancer progression and
metastasis: An essential role for ADRB2. Cell Death Dis.
10:7882019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valente VB, de Melo Cardoso D, Kayahara
GM, Nunes GB, Tjioe KC, Biasoli ÉR, Miyahara GI, Oliveira SHP,
Mingoti GZ and Bernabé DG: Stress hormones promote DNA damage in
human oral keratinocytes. Sci Rep. 11:197012021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wani TH, Surendran S, Mishra VS,
Chaturvedi J, Chowdhury G and Chakrabarty A: Adaptation to chronic
exposure to sepantronium bromide (YM155), a prototypical survivin
suppressant is due to persistent DNA damage-response in breast
cancer cells. Oncotarget. 9:33589–33600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pechackova S, Burdova K and Macurek L:
WIP1 phosphatase as pharmacological target in cancer therapy. J Mol
Med (Berl). 95:589–599. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fiscella M, Zhang H, Fan S, Sakaguchi K,
Shen S, Mercer WE, Woude GFV, O'Connor PM and Appella E: Wip1, a
novel human protein phosphatase that is induced in response to
ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci
USA. 94:6048–6053. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rodriguez A, Naveja JJ, Torres L, de
Teresa BG, Juarez-Figueroa U, Ayala-Zambrano C, Azpeitia E, Mendoza
L and Frías S: WIP1 contributes to the adaptation of Fanconi anemia
cells to DNA damage as determined by the regulatory network of the
Fanconi anemia and checkpoint recovery pathways. Front Genet.
10:4112019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng R, Qu C, Zhang S, Zeng H, Sun K, Gu
X, Xia C, Yang Z, Li H, Wei W, et al: Liver cancer incidence and
mortality in China: Temporal trends and projections to 2030. Chin J
Cancer Res. 30:571–579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li GB, Zhang XL, Yuan L, Jiao QQ, Liu DJ
and Liu J: Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA
expression is a prognosis marker for hepatocellular carcinoma. PLoS
One. 8:e607752013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu Z, Cao C, Xia H, Shi S, Hong L, Wei X,
Gu D, Bian J, Liu Z, Huang W, et al: Protein phosphatase
magnesium-dependent 1δ is a novel tumor marker and target in
hepatocellular carcinoma. Front Med. 10:52–60. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zegura B, Sedmak B and Filipic M:
Microcystin-LR induces oxidative DNA damage in human hepatoma cell
line HepG2. Toxicon. 41:41–48. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang W, Liu Y, Wang J, Yuan X, Jin HW,
Zhang LR, Zhang JT, Liu ZM and Cui JR: Small-molecule compounds
targeting the STAT3 DNA-binding domain suppress survival of
cisplatin-resistant human ovarian cancer cells by inducing
apoptosis. Eur J Med Chem. 157:887–897. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang W, Yuan X, Sun T, Fan S, Wang J,
Zhou Q, Guo W, Ran F, Ge Z, Yang H, et al: Proteasome inhibitor
YSY01A abrogates constitutive STAT3 signaling via down-regulation
of Gp130 and JAK2 in human A549 lung cancer cells. Front Pharmacol.
8:4762017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kao SH, Wang WL, Chen CY, Chang YL, Wu YY,
Wang YT, Wang SP, Nesvizhskii AI, Chen YJ, Hong TM and Yang PC:
Analysis of protein stability by the cycloheximide chase assay. Bio
Protoc. 5:e13742015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang W, Dong Z, Wang F, Peng H, Liu JY
and Zhang JT: A small molecule compound targeting STAT3 DNA-binding
domain inhibits cancer cell proliferation, migration, and invasion.
ACS Chem Biol. 9:1188–1196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang W, Dong Z, Chen Y, Wang F, Wang CJ,
Peng H, He Y, Hangoc G, Pollok K, Sandusky G, et al: Small-molecule
inhibitors targeting the DNA-binding domain of STAT3 suppress tumor
growth, metastasis and STAT3 target gene expression in vivo.
Oncogene. 35:783–792. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang W, Zhou Q, Yuan X, Ge ZM, Ran FX,
Yang HY, Qiang GL, Li RT and Cui JR: Proteasome inhibitor YSY01A
enhances cisplatin cytotoxicity in cisplatin-resistant human
ovarian cancer cells. J Cancer. 7:1133–1141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tapryal N, Vivek GV and Mukhopadhyay CK:
Catecholamine stress hormones regulate cellular iron homeostasis by
a posttranscriptional mechanism mediated by iron regulatory
protein: Implication in energy homeostasis. J Biol Chem.
290:7634–7646. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ma J, Xue M, Zhang S, Cheng L, Qian W,
Duan W and Shen X: Resveratrol inhibits the growth of tumor cells
under chronic stress via the ADRB-2-HIF-1α axis. Oncol Rep.
41:1051–1058. 2019.PubMed/NCBI
|
|
47
|
Cayla C, Schaak S, Roquelaine C, Gales C,
Quinchon F and Paris H: Homologous regulation of the
α2C-adrenoceptor subtype in human hepatocarcinoma, HepG2. Br J
Pharmacol. 126:69–78. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Uen YH, Ko PH, Yin PH, Liu TY, Chi CW and
Lui WY: Glucocorticoid protects hepatoma cells against metabolic
stress-induced cell death. Int J Oncol. 33:1263–1270.
2008.PubMed/NCBI
|
|
49
|
Li M, Chen F, Liu CP, Li DM, Li X, Wang C
and Li JC: Dexamethasone enhances trichosanthin-induced apoptosis
in the HepG2 hepatoma cell line. Life Sci. 86:10–16. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Oliver AW, Paul A, Boxall KJ, Barrie SE,
Aherne GW, Garrett MD, Mittnacht S and Pearl LH: Trans-activation
of the DNA-damage signalling protein kinase Chk2 by T-loop
exchange. EMBO J. 25:3179. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Reinhardt HC and Yaffe MB: Kinases that
control the cell cycle in response to DNA damage: Chk1, Chk2, and
MK2. Curr Opin Cell Biol. 21:245–255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shi T, van Soest DMK, Polderman PE,
Burgering BMT and Dansen TB: DNA damage and oxidizing conditions
activate p53 through differential upstream signaling pathways. Free
Radic Biol Med. 172:298–311. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ozaki T and Nakagawara A: Role of p53 in
cell death and human cancers. Cancers (Basel). 3:994–1013. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang XP, Liu F and Wang W: Two-phase
dynamics of p53 in the DNA damage response. Proc Natl Acad Sci USA.
108:8990–8995. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ogunwobi OO, Harricharran T, Huaman J,
Galuza A, Odumuwagun O, Tan Y, Ma GX and Nguyen MT: Mechanisms of
hepatocellular carcinoma progression. World J Gastroenterol.
25:2279–2293. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sood AK, Bhatty R, Kamat AA, Landen CN,
Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S and Cole SW:
Stress hormone-mediated invasion of ovarian cancer cells. Clin
Cancer Res. 12:369–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Reeder A, Attar M, Nazario L, Bathula C,
Zhang A, Hochbaum D, Roy E, Cooper KL, Oesterreich S, Davidson NE,
et al: Stress hormones reduce the efficacy of paclitaxel in triple
negative breast cancer through induction of DNA damage. Br J
Cancer. 112:1461–1470. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Alyusuf R, Wazir JF, Brahmi UP, Fakhro AR
and Bakhiet M: The immunoexpression of glucocorticoid receptors in
breast carcinomas, lactational change, and normal breast epithelium
and its possible role in mammary carcinogenesis. Int J Breast
Cancer. 2017:14030542017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Maki T, Kontula K and Harkonen M: The
β-adrenergic system in man: Physiological and pathophysiological
response. Regulation of receptor density and functioning. Scand J
Clin Lab Invest Suppl. 201:25–43. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lorton D and Bellinger DL: Molecular
mechanisms underlying β-adrenergic receptor-mediated cross-talk
between sympathetic neurons and immune cells. Int J Mol Sci.
16:5635–5665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Escoter-Torres L, Caratti G, Mechtidou A,
Tuckermann J, Uhlenhaut NH and Vettorazzi S: Fighting the fire:
Mechanisms of inflammatory gene regulation by the glucocorticoid
receptor. Front Immunol. 10:18592019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lindström MS, Bartek J and Maya-Mendoza A:
p53 at the crossroad of DNA replication and ribosome biogenesis
stress pathways. Cell Death Differ. 29:972–982. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Molinaro C, Martoriati A and Cailliau K:
Proteins from the DNA damage response: Regulation, dysfunction, and
anticancer strategies. Cancers (Basel). 13:38192021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Weitzman MD and Weitzman JB: What's the
Damage? The impact of pathogens on pathways that maintain host
genome integrity. Cell Host Microbe. 15:283–294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lambros MB, Natrajan R, Geyer FC,
Lopez-Garcia MA, Dedes KJ, Savage K, Lacroix-Triki M, Jones RL,
Lord CJ, Linardopoulos S, et al: PPM1D gene amplification and
overexpression in breast cancer: a qRT-PCR and chromogenic in situ
hybridization study. Mod Pathol. 23:1334–1345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Peng TS, He YH, Nie T, Hu XD, Lu HY, Yi J,
Shuai YF and Luo M: PPM1D is a prognostic marker and therapeutic
target in colorectal cancer. Exp Ther Med. 8:430–434. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sun GG, Wang YD, Liu Q and Hu WN:
Expression of Wip1 in kidney carcinoma and its correlation with
tumor metastasis and clinical significance. Pathol Oncol Res.
21:219–224. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Fuku T, Semba S, Yutori H and Yokozaki H:
Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D)
expression correlated with downregulation of checkpoint kinase 2 in
human gastric carcinoma. Pathol Int. 57:566–571. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Carr MI and Jones SN: Regulation of the
Mdm2-p53 signaling axis in the DNA damage response and
tumorigenesis. Transl Cancer Res. 5:707–724. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Feroz W and Sheikh AMA: Exploring the
multiple roles of guardian of the genome: P53. Egypt J Med Hum
Genet. 21:492020. View Article : Google Scholar
|
|
71
|
Choi DW, Na W, Kabir MH, Yi E, Kwon S,
Yeom J, Ahn JW, Choi HH, Lee Y, Seo KW, et al: WIP1, a homeostatic
regulator of the DNA damage response, is targeted by HIPK2 for
phosphorylation and degradation. Mol Cell. 51:374–385. 2013.
View Article : Google Scholar : PubMed/NCBI
|
